|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| G01N 33/68 |
| (11) | Number of the document | 2247954 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09774994.9 |
| Date of filing the European patent application | 2009-11-20 | |
| (97) | Date of publication of the European application | 2010-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/006269 |
| Date | 2009-11-20 |
| (87) | Number | WO 2010/085235 |
| Date | 2010-07-29 |
| (30) | Number | Date | Country code |
| 321393 | 2009-01-20 | US |
| (72) |
RÖDER, Heinrich, US
TSYPIN, Maxim, US
GRIGORIEVA, Julia, US
|
| (73) |
Biodesix Inc.,
P.O. Box 774872 1370 Bob Adams Drive, Steamboat Springs, CO 80477,
US
|
| (54) | SELECTION OF HEAD AND NECK CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY |
| SELECTION OF HEAD AND NECK CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY |